Conducting Oncology Clinical Trials in Africa II: Strategies for Building Needed Research Infrastructure for Clinical Trials

COVID-19: Managing paediatric patients under the COVID pandemic

Conducting Oncology Clinical Trials in Africa II: Innovative recruitment methods for oncology clinical trials

Meet the Expert: Dr Bodour Salhia

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma

Meet the Expert: Prof Ifeoma Okoye

Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated melanoma

An oncologist's experience of managing breast cancer during the COVID-19 outbreak

COVID-19: The situation in Florida and managing lung cancer patients

Conducting Oncology Clinical Trials in Africa II: Developing direction for the management of clinical trials in Africa

COVID-19: What can be learned from Australia's approach

New oncogenic drivers in NSCLC